COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT04648800


Column Value
Trial registration number NCT04648800
Full text link
Last imported at : Dec. 3, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

First author
Last imported at : Dec. 3, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

Artur Mazur, prof.

Contact
Last imported at : Dec. 3, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

prorektor.cm@ur.edu.pl

Registration date
Last imported at : Dec. 3, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

2020-12-02

Recruitment status
Last imported at : Nov. 7, 2022, noon
Source : ClinicalTrials.gov

Unknown

Study design
Last imported at : Dec. 3, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : Dec. 3, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : Dec. 3, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : Dec. 3, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

Blind label

Center
Last imported at : Dec. 3, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

multi-center

Study aim
Last imported at : Dec. 3, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

Prevention

Inclusion criteria
Last imported at : Dec. 3, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

inclusion criteria: - a health care professional (physician, nurse, midwife, paramedic, electroradiology technician, laboratory diagnostician, physiotherapist, nutritionist, orderly) aged >25 years - no confirmed sars-cov-2 infection - informed consent to participate in the trial and consent to personal data processing - declared availability for telephone contacts throughout the study period - good health condition - earlier vaccination against tuberculosis

Exclusion criteria
Last imported at : Dec. 3, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

- hypersensitivity to any component of bcg-10 - hypersensitivity to previously administered tuberculin (local skin lesions, necrosis of the skin, blisters, other severe skin reactions at the injection site) - hiv infection (confirmed or suspected infections, even if they are asymptomatic) - primary or secondary immunodeficiencies (including interferon - gamma deficiency or digeorge syndrome) - radiotherapy (less than 24 months before the date of inclusion in the trial - treatment with corticosteroids, ongoing immunosuppressive therapy (including those treated with monoclonal antibodies to tnf-α, such as infliximab) - less than 24 months before the date of inclusion in the trial - neoplastic diseases (e.g. leukaemia, malignant granuloma, lymphoma or some other cancer of the reticuloendothelial system) - less than 24 months before the date of inclusion in the study - after stem cell transplantation and organ transplantation - in the exacerbation stage of chronic diseases (including severe malnutrition) - pregnancy - history of tuberculosis - keloid at the vaccination site after previous bcg vaccination

Number of arms
Last imported at : Dec. 3, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

3

Funding
Last imported at : Dec. 3, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

Hanna Czajka

Inclusion age min
Last imported at : Dec. 3, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

25

Inclusion age max
Last imported at : Dec. 3, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

100

Countries
Last imported at : Dec. 3, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

Poland

Type of patients
Last imported at : Dec. 3, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

Health workers

Severity scale
Last imported at : Dec. 3, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

N/A

Total sample size
Last imported at : Dec. 3, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

1000

primary outcome
Last imported at : Dec. 3, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

death and life- or health-threatening condition (cardiac arrest with effective resuscitation, shock, severe respiratory failure, severe renal failure, stroke/transient cerebral ischaemia)

Notes
Last imported at : Dec. 3, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

None

Phase
Last imported at : Feb. 25, 2021, 7:58 p.m.
Source : ClinicalTrials.gov

Phase 3

Arms
Last imported at : Dec. 3, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

[{"arm_notes": "", "treatment_id": 186, "treatment_name": "Bcg vaccine", "treatment_type": "Non covid vaccine", "pharmacological_treatment": "Non covid vaccine"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]